Jan 14 (Reuters) - Structure Therapeutics' CEO expects oral weight-loss pills to capture as much as half of the GLP-1 market by 2030, driven partly by pent-up demand from patients and doctors.

Craftee discovers structures now have hidden secret abilities. Trump administration proposes Colorado River options that could hit California hard After Trump attack, RTX decides that winning move is ...

Researchers successfully used stem cells to grow mouse kidneys inside rats. In a study with significant implications for human organ transplantation, researchers have successfully grown functional ...

New! Sign up for our free email newsletter.